Artigo de periodico

Immunodominant B cell epitope in SARS-CoV-2 RBD comprises a B.1.351 and P.1 mutation hotspot: implications for viral spread and antibody escape (2021)

• Authors:
  • Santos, Keity Souza
  • Oliveira, Jamille Ramos de
  • Machado, Rafael Rahal Guaragna
  • Arcuri, Helen Andrade
  • Magawa, Jhosiene Yukari
  • Daher, Isabela Pazotti
  • Urbanski, Alysson Henrique
  • Schmitz, Gabriela Justamante Handel
  • Silva Júnior, Roberto Carlos Vieira
  • Durigon, Edison Luiz
  • Boscardin, Silvia Beatriz
  • Rosa, Daniela Santoro
  • Schechtman, Deborah
  • Cunha Neto, Edecio
  • Gadermaier, Gabriele
  • Coelho, Verônica Porto Carreiro de Vasconcellos
  • Kalil, Jorge
  • Nakaya, Helder Takashi Imoto
• USP affiliated authors: SANTOS, KEITY SOUZA - FM ; DURIGON, EDISON LUIZ - ICB ; BOSCARDIN, SILVIA BEATRIZ - ICB ; SCHECHTMAN, DEBORAH - IQ ; NAKAYA, HELDER TAKASHI IMOTO - FCF ; CUNHA NETO, EDECIO - FM ; COELHO, VERONICA PORTO CARREIRO DE VASCONCELLOS - FM ; SILVA JUNIOR, ROBERTO CARLOS VIEIRA DA - ICB ; URBANSKI, ALYSSON HENRIQUE - FCF ; MACHADO, RAFAEL RAHAL GUARAGNA - ICB ; OLIVEIRA, JAMILLE RAMOS DE - FM ; MAGAWA, JHOSIENE YUKARI - FM ; DAHER, ISABELA PAZOTTI - FM ; SCHMITZ, GABRIELA JUSTAMANTE HANDEL - FM
• Unidades: FM; ICB; IQ; FCF
• DOI: 10.1101/2021.03.11.21253399
• Subjects: EPITOPOS; COVID-19; ANTICORPOS
• Agências de fomento:
  • Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
    Processo FAPESP: 2020/05256-7
  • Financiamento FINEP
• Language: Inglês
• Imprenta:
  • Publisher place: New York
  • Date published: 2021
• Source:
  • Título: medRxiv (The Preprint Server For Health Sciences)
  • Volume/Número/Paginação/Ano: Preprint, 18 p., 2021

Informações sobre o DOI: 10.1101/2021.03.11.21253399 (Fonte: oaDOI API)
• Este periódico é de assinatura
• Este artigo NÃO é de acesso aberto
  
• Cor do Acesso Aberto: closed

---

Download do texto completo

Tipo	Nome	Link
	3025074.pdf	Direct link

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  SANTOS, Keity Souza et al. Immunodominant B cell epitope in SARS-CoV-2 RBD comprises a B.1.351 and P.1 mutation hotspot: implications for viral spread and antibody escape. medRxiv (The Preprint Server For Health Sciences), p. 18 , 2021Tradução . . Disponível em: https://doi.org/10.1101/2021.03.11.21253399. Acesso em: 02 out. 2024.

• APA

  Santos, K. S., Oliveira, J. R. de, Machado, R. R. G., Arcuri, H. A., Magawa, J. Y., Daher, I. P., et al. (2021). Immunodominant B cell epitope in SARS-CoV-2 RBD comprises a B.1.351 and P.1 mutation hotspot: implications for viral spread and antibody escape. medRxiv (The Preprint Server For Health Sciences), 18 . doi:10.1101/2021.03.11.21253399

• NLM

  Santos KS, Oliveira JR de, Machado RRG, Arcuri HA, Magawa JY, Daher IP, Urbanski AH, Schmitz GJH, Silva Júnior RCV, Durigon EL, Boscardin SB, Rosa DS, Schechtman D, Cunha Neto E, Gadermaier G, Coelho VPC de V, Kalil J, Nakaya HTI. Immunodominant B cell epitope in SARS-CoV-2 RBD comprises a B.1.351 and P.1 mutation hotspot: implications for viral spread and antibody escape [Internet]. medRxiv (The Preprint Server For Health Sciences). 2021 ; 18 .[citado 2024 out. 02 ] Available from: https://doi.org/10.1101/2021.03.11.21253399

• Vancouver

  Santos KS, Oliveira JR de, Machado RRG, Arcuri HA, Magawa JY, Daher IP, Urbanski AH, Schmitz GJH, Silva Júnior RCV, Durigon EL, Boscardin SB, Rosa DS, Schechtman D, Cunha Neto E, Gadermaier G, Coelho VPC de V, Kalil J, Nakaya HTI. Immunodominant B cell epitope in SARS-CoV-2 RBD comprises a B.1.351 and P.1 mutation hotspot: implications for viral spread and antibody escape [Internet]. medRxiv (The Preprint Server For Health Sciences). 2021 ; 18 .[citado 2024 out. 02 ] Available from: https://doi.org/10.1101/2021.03.11.21253399

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape
• Time-dependent contraction of the SARS-CoV-2–specific T-cell responses in convalescent individuals
• The oldest unvaccinated Covid-19 survivors in South America
• Distinct anti-NP, anti-RBD and anti-Spike antibody profiles discriminate death from survival in COVID-19
• Cross-lineage protection between chikv primary infection and mayv secondary exposure in mice
• Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial
• ZnO-Based electrochemical immunosensor to assess vaccine-induced antibody-mediated immunity against Wild-Type and Gamma SARS-CoV-2 strains
• Análise comparativa dos proteomas das raízes tuberosas de mandioca (Manihot esculenta Crantz) de variedades de mesa e indústria
• Investigação de marcadores moleculares sanguíneos durante a infecção pelo vírus Chikungunya
• A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti‐nucleocapsid (NP) SARS‐CoV‐2 antibody kinetics: proposals for better quality of CCP collections